Genetic control of murine invariant natural killer T cells maps to multiple type 1 diabetes regions

Genes and Immunity

Volumn 14, Issue 6, 2013, Pages 380-386

  Tsaih, S W ^a   Khaja, S ^a   Ciecko, A E ^a   MacKinney, E ^a   Chen, Y G ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

autoimmunity; iNKT cell; linkage analysis; NOD mouse

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CELL MATURATION; CHROMOSOME 1; CHROMOSOME 12; CHROMOSOME 17; CHROMOSOME 4; CHROMOSOME 5; CHROMOSOME 6; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENE MAPPING; GENETIC REGULATION; GENETIC SUSCEPTIBILITY; INSTITUTE FOR CANCER RESEARCH MOUSE; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE SUBPOPULATION; MALE; MARKER GENE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; NONOBESE DIABETIC MOUSE; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS MAPPING; SPLEEN CELL; THYMOCYTE;

MURINAE; MUS;

ANIMALS; CHROMOSOMES, MAMMALIAN; DIABETES MELLITUS, TYPE 1; GENETIC LINKAGE; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; MALE; MICE; MICE, INBRED ICR; MICE, INBRED NOD; NATURAL KILLER T-CELLS; QUANTITATIVE TRAIT LOCI; SPLEEN; T-LYMPHOCYTE SUBSETS; THYMUS GLAND;

EID: 84883850847     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2013.32     Document Type: Article

References (51)

1. Bendelac A, Savage PB, Teyton L. The biology of NKT cells. Annu Rev Immunol 2007; 25: 297-336. (Pubitemid 46697911)
2. Coquet JM, Chakravarti S, Kyparissoudis K, McNab FW, Pitt LA, McKenzie BS et al. Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4-NK1.1-NKT cell population. Proc Natl Acad Sci USA 2008; 105: 11287-11292.
3. Michel ML, Keller AC, Paget C, Fujio M, Trottein F, Savage PB et al. Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia. J Exp Med 2007; 204: 995-1001. (Pubitemid 46798144)
4. Matsuda JL, Mallevaey T, Scott-Browne J, Gapin L. CD1d-restricted iNKT cells, the 'Swiss-Army knife' of the immune system. Curr Opin Immunol 2008; 20: 358-368.
5. Chan AC, Serwecinska L, Cochrane A, Harrison LC, Godfrey DI, Berzins SP. Immune characterization of an individual with an exceptionally high natural killer T cell frequency and her immediate family. Clin Exp Immunol 2009; 156: 238-245.
6. Montoya CJ, Pollard D, Martinson J, Kumari K, Wasserfall C, Mulder CB et al. Characterization of human invariant natural killer T subsets in health and disease using a novel invariant natural killer T cell-clonotypic monoclonal antibody, 6B11. Immunology 2007; 122: 1-14. (Pubitemid 47222606)
7. Kis J, Engelmann P, Farkas K, Richman G, Eck S, Lolley J et al. Reduced CD4\+ subset and Th1 bias of the human iNKT cells in Type 1 diabetes mellitus. J Leukoc Biol 2007; 81: 654-662. (Pubitemid 46393543)
8. Berzins SP, Cochrane AD, Pellicci DG, Smyth MJ, Godfrey DI. Limited correlation between human thymus and blood NKT cell content revealed by an ontogeny study of paired tissue samples. Eur J Immunol 2005; 35: 1399-1407. (Pubitemid 40691421)
9. Lee PT, Putnam A, Benlagha K, Teyton L, Gottlieb PA, Bendelac A. Testing the NKT cell hypothesis of human IDDM pathogenesis. J Clin Invest 2002; 110: 793-800.
10. Rymarchyk SL, Lowenstein H, Mayette J, Foster SR, Damby DE, Howe IW et al. Widespread natural variation in murine natural killer T-cell number and function. Immunology 2008; 125: 331-343.
11. Chen YG, Tsaih SW, Serreze DV. Genetic control of murine invariant natural killer T-cell development dynamically differs dependent on the examined tissue type. Genes Immun 2012; 13: 164-174.
12. Berzins SP, Smyth MJ, Baxter AG. Presumed guilty: natural killer T cell defects and human disease. Nat Rev Immunol 2011; 11: 131-142.
13. Wilson SB, Delovitch TL. Janus-like role of regulatory iNKT cells in autoimmune disease and tumour immunity. Nat Rev Immunol 2003; 3: 211-222. (Pubitemid 37323206)
14. Naumov YN, Bahjat KS, Gausling R, Abraham R, Exley MA, Koezuka Y et al. Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets. Proc Natl Acad Sci USA 2001; 98: 13838-13843. (Pubitemid 33115985)
15. Hong S, Wilson MT, Serizawa I, Wu L, Singh N, Naidenko OV et al. The natural killer T-cell ligand alpha-galactosylceramide prevents autoimmune diabetes in nonobese diabetic mice. Nat Med 2001; 7: 1052-1056. (Pubitemid 32937387)
16. Sharif S, Arreaza GA, Zucker P, Mi QS, Sondhi J, Naidenko OV et al. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat Med 2001; 7: 1057-1062. (Pubitemid 32937388)
17. Wang B, Geng YB, Wang CR. CD1-restricted NK T cells protect nonobese diabetic mice from developing diabetes. J Exp Med 2001; 194: 313-320.
18. Shi FD, Flodstrom M, Balasa B, Kim SH, Van Gunst K, Strominger JL et al. Germ line deletion of the CD1 locus exacerbates diabetes in the NOD mouse. Proc Natl Acad Sci USA 2001; 98: 6777-6782. (Pubitemid 32538293)
19. Lehuen A, Lantz O, Beaudoin L, Laloux V, Carnaud C, Bendelac A et al. Overexpression of natural killer T cells protects Valpha14-Jalpha281 transgenic nonobese diabetic mice against diabetes. J Exp Med 1998; 188: 1831-1839. (Pubitemid 28536770)
20. Hammond KJ, Poulton LD, Palmisano LJ, Silveira PA, Godfrey DI, Baxter AG alpha/beta-T cell receptor (TCR)\+CD4-CD8-(NKT) thymocytes prevent insulindependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10. J Exp Med 1998; 187: 1047-1056. (Pubitemid 28176405)
21. Zekavat G, Mozaffari R, Arias VJ, Rostami SY, Badkerhanian A, Tenner AJ et al. A novel CD93 polymorphism in non-obese diabetic (NOD) and NZB/W F1 mice is linked to a CD4\+ iNKT cell deficient state. Immunogenetics 2010; 62: 397-407.
22. Ueno A, Wang J, Cheng L, Im JS, Shi Y, Porcelli SA et al. Enhanced early expansion and maturation of semi-invariant NK T cells inhibited autoimmune pathogenesis in congenic nonobese diabetic mice. J Immunol 2008; 181: 6789-6796.
23. Fletcher JM, Jordan MA, Snelgrove SL, Slattery RM, Dufour FD, Kyparissoudis K et al. Congenic analysis of the NKT cell control gene Nkt2 implicates the peroxisomal protein Pxmp4. J Immunol 2008; 181: 3400-3412.
24. Chen YG, Driver JP, Silveira PA, Serreze DV. Subcongenic analysis of genetic basis for impaired development of invariant NKT cells in NOD mice. Immunogenetics 2007; 59: 705-712. (Pubitemid 47415563)
25. Matsuki N, Stanic AK, Embers ME, Van Kaer L, Morel L, Joyce S. Genetic dissection of V alpha 14J alpha 18 natural T cell number and function in autoimmune-prone mice. J Immunol 2003; 170: 5429-5437. (Pubitemid 36617829)
26. Esteban LM, Tsoutsman T, Jordan MA, Roach D, Poulton LD, Brooks A et al. Genetic control of NKT cell numbers maps to major diabetes and lupus loci. J Immunol 2003; 171: 2873-2878. (Pubitemid 37093507)
27. Jordan MA, Fletcher JM, Jose R, Chowdhury S, Gerlach N, Allison J et al. Role of Slam in NKT cell development revealed by transgenic complementation in NOD mice. J Immunol 2011; 186: 3953-3965.
28. Jordan MA, Fletcher JM, Pellicci D, Baxter AG. Slamf1, the NKT cell control gene Nkt1. J Immunol 2007; 178: 1618-1627. (Pubitemid 46154633)
29. Griewank K, Borowski C, Rietdijk S, Wang N, Julien A, Wei DG et al. Homotypic interactions mediated by Slamf1 and Slamf6 receptors control NKT cell lineage development. Immunity 2007; 27: 751-762. (Pubitemid 350102258)
30. Kukreja A, Cost G, Marker J, Zhang C, Sun Z, Lin-Su K et al. Multiple immunoregulatory defects in type-1 diabetes. J Clin Invest 2002; 109: 131-140. (Pubitemid 34052549)
31. Wilson SB, Kent SC, Patton KT, Orban T, Jackson RA, Exley M et al. Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes. Nature 1998; 391: 177-181. (Pubitemid 28092476)
32. Roman-Gonzalez A, Moreno ME, Alfaro JM, Uribe F, Latorre-Sierra G, Rugeles MT et al. Frequency and function of circulating invariant NKT cells in autoimmune diabetes mellitus and thyroid diseases in Colombian patients. Hum Immunol 2009; 70: 262-268.
33. Nakamura T, Sonoda KH, Faunce DE, Gumperz J, Yamamura T, Miyake S et al. CD4\+ NKT cells, but not conventional CD4\+ T cells, are required to generate efferent CD8\+ T regulatory cells following antigen inoculation in an immuneprivileged site. J Immunol 2003; 171: 1266-1271. (Pubitemid 36900056)
34. Roelofs-Haarhuis K, Wu X, Gleichmann E. Oral tolerance to nickel requires CD4\+ invariant NKT cells for the infectious spread of tolerance and the induction of specific regulatory T cells. J Immunol 2004; 173: 1043-1050. (Pubitemid 38924278)
35. Terabe M, Matsui S, Noben-Trauth N, Chen H, Watson C, Donaldson DD et al. NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4RSTAT6 pathway. Nat Immunol 2000; 1: 515-520.
36. Chen YG, Chen J, Osborne MA, Chapman HD, Besra GS, Porcelli SA et al. CD38 is required for the peripheral survival of immunotolerogenic CD4\+ invariant NK T cells in nonobese diabetic mice. J Immunol 2006; 177: 2939-2947. (Pubitemid 44277809)
37. Simoni Y, Gautron AS, Beaudoin L, Bui LC, Michel ML, Coumoul X et al. NOD mice contain an elevated frequency of iNKT17 cells that exacerbate diabetes. Eur J Immunol 2011; 41: 3574-3585.
38. Leiter EA (eds). NOD Mice and Related Strains: Research Applications in Diabetes AIDS, Cancer and other Diseases. R.G. Lands Company: Austin, TX, USA, 1998.
39. Wallace C, Smyth DJ, Maisuria-Armer M, Walker NM, Todd JA, Clayton DG. The imprinted DLK1-MEG3 gene region on chromosome 14q32.2 alters susceptibility to type 1 diabetes. Nat Genet 2010; 42: 68-71.
40. Serreze DV, Prochazka M, Reifsnyder PC, Bridgett MM, Leiter EH. Use of recombinant congenic and congenic strains of NOD mice to identify a new insulin-dependent diabetes resistance gene. J Exp Med 1994; 180: 1553-1558. (Pubitemid 24289630)
41. Ivakine EA, Fox CJ, Paterson AD, Mortin-Toth SM, Canty A, Walton DS et al. Sexspecific effect of insulin-dependent diabetes 4 on regulation of diabetes pathogenesis in the nonobese diabetic mouse. J Immunol 2005; 174: 7129-7140. (Pubitemid 40705679)
42. Godfrey DI, Berzins SP. Control points in NKT-cell development. Nat Rev Immunol 2007; 7: 505-518. (Pubitemid 46987785)
43. Godfrey DI, Stankovic S, Baxter AG. Raising the NKT cell family. Nat Immunol 2010; 11: 197-206.
44. Ziegler AG, Nepom GT. Prediction and pathogenesis in type 1 diabetes. Immunity 2010; 32: 468-478.
45. McAleer MA, Reifsnyder P, Palmer SM, Prochazka M, Love JM, Copeman JB et al. Crosses of NOD mice with the related NON strain. A polygenic model for IDDM. Diabetes 1995; 44: 1186-1195.
46. Driver JP, Serreze DV, Chen YG. Mouse models for the study of autoimmune type 1 diabetes: a NOD to similarities and differences to human disease. Semin Immunopathol 2011; 33: 67-87.
47. Collaborative Cross Consortium. The genome architecture of the Collaborative Cross mouse genetic reference population. Genetics 2012; 190: 389-401.
48. Cox A, Ackert-Bicknell CL, Dumont BL, Ding Y, Bell JT, Brockmann GA et al. A new standard genetic map for the laboratory mouse. Genetics 2009; 182: 1335-1344.
49. Broman KW, Wu H, Sen S, Churchill GA. R/qtl: QTL mapping in experimental crosses. Bioinformatics 2003; 19: 889-890. (Pubitemid 36582406)
50. Sen S, Churchill GA. A statistical framework for quantitative trait mapping. Genetics 2001; 159: 371-387. (Pubitemid 32917385)
51. Wergedal JE, Ackert-Bicknell CL, Tsaih SW, Sheng MH, Li R, Mohan S et al. Femur mechanical properties in the F2 progeny of an NZB/B1NJ x RF/J cross are regulated predominantly by genetic loci that regulate bone geometry. J Bone Miner Res 2006; 21: 1256-1266. (Pubitemid 44128339)